SHILPA MEDICARE
|
SHILPA MEDICARE Last 5 Year Balance Sheet History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹9.78 Cr | ₹8.68 Cr | ₹8.68 Cr | ₹8.68 Cr | ₹8.15 Cr |
Equity - Authorised | ₹11 Cr | ₹11 Cr | ₹9.50 Cr | ₹9.50 Cr | ₹9.50 Cr |
Equity - Issued | ₹9.78 Cr | ₹8.68 Cr | ₹8.68 Cr | ₹8.68 Cr | ₹8.15 Cr |
Equity Paid Up | ₹9.78 Cr | ₹8.68 Cr | ₹8.68 Cr | ₹8.68 Cr | ₹8.15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹2,362 Cr | ₹1,800 Cr | ₹1,775 Cr | ₹1,814 Cr | ₹1,471 Cr |
Securities Premium | ₹1,213 Cr | ₹725 Cr | ₹725 Cr | ₹725 Cr | ₹429 Cr |
Capital Reserves | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr |
Profit & Loss Account Balance | ₹1,097 Cr | ₹1,034 Cr | ₹1,001 Cr | ₹1,043 Cr | ₹992 Cr |
General Reserves | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹52 Cr |
Other Reserves | ₹0.50 Cr | ₹-11 Cr | ₹-3.45 Cr | ₹-6.56 Cr | ₹-1.55 Cr |
Reserve excluding Revaluation Reserve | ₹2,362 Cr | ₹1,800 Cr | ₹1,775 Cr | ₹1,814 Cr | ₹1,471 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,372 Cr | ₹1,809 Cr | ₹1,783 Cr | ₹1,822 Cr | ₹1,479 Cr |
Minority Interest | ₹-8.54 Cr | ₹-8.74 Cr | ₹-8.92 Cr | ₹-11 Cr | ₹-11 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹232 Cr | ₹560 Cr | ₹243 Cr | ₹353 Cr | ₹474 Cr |
Non Convertible Debentures | ₹75 Cr | ₹450 Cr | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹157 Cr | ₹110 Cr | ₹243 Cr | ₹353 Cr | ₹474 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | ₹46 Cr | ₹0.11 Cr | ₹0.35 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹0.11 Cr | ₹0.32 Cr |
Other Unsecured Loan | - | - | ₹46 Cr | - | ₹0.03 Cr |
Deferred Tax Assets / Liabilities | ₹-13 Cr | ₹-10 Cr | ₹14 Cr | ₹55 Cr | ₹47 Cr |
Deferred Tax Assets | ₹191 Cr | ₹186 Cr | ₹156 Cr | ₹118 Cr | ₹65 Cr |
Deferred Tax Liability | ₹178 Cr | ₹176 Cr | ₹170 Cr | ₹173 Cr | ₹112 Cr |
Other Long Term Liabilities | ₹15 Cr | ₹17 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹26 Cr | ₹22 Cr | ₹18 Cr | ₹19 Cr | ₹15 Cr |
Total Non-Current Liabilities | ₹260 Cr | ₹589 Cr | ₹345 Cr | ₹453 Cr | ₹561 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹95 Cr | ₹174 Cr | ₹143 Cr | ₹146 Cr | ₹77 Cr |
Sundry Creditors | ₹95 Cr | ₹174 Cr | ₹143 Cr | ₹146 Cr | ₹77 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹222 Cr | ₹138 Cr | ₹277 Cr | ₹240 Cr | ₹254 Cr |
Bank Overdraft / Short term credit | - | ₹0.01 Cr | ₹2.49 Cr | ₹8.49 Cr | - |
Advances received from customers | ₹14 Cr | ₹5.15 Cr | ₹11 Cr | ₹16 Cr | ₹7.48 Cr |
Interest Accrued But Not Due | ₹0.73 Cr | ₹2.06 Cr | ₹2.78 Cr | ₹2.29 Cr | ₹2.64 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹207 Cr | ₹131 Cr | ₹260 Cr | ₹213 Cr | ₹244 Cr |
Short Term Borrowings | ₹307 Cr | ₹361 Cr | ₹344 Cr | ₹203 Cr | ₹243 Cr |
Secured ST Loans repayable on Demands | ₹307 Cr | ₹361 Cr | ₹344 Cr | ₹203 Cr | ₹243 Cr |
Working Capital Loans- Sec | ₹307 Cr | ₹361 Cr | ₹344 Cr | ₹203 Cr | ₹243 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-307 Cr | ₹-361 Cr | ₹-344 Cr | ₹-203 Cr | ₹-243 Cr |
Short Term Provisions | ₹50 Cr | ₹21 Cr | ₹21 Cr | ₹22 Cr | ₹13 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹50 Cr | ₹21 Cr | ₹21 Cr | ₹22 Cr | ₹13 Cr |
Total Current Liabilities | ₹674 Cr | ₹694 Cr | ₹784 Cr | ₹612 Cr | ₹587 Cr |
Total Liabilities | ₹3,298 Cr | ₹3,083 Cr | ₹2,904 Cr | ₹2,875 Cr | ₹2,632 Cr |
ASSETS | |||||
Gross Block | ₹2,076 Cr | ₹1,947 Cr | ₹1,847 Cr | ₹1,727 Cr | ₹1,421 Cr |
Less: Accumulated Depreciation | ₹658 Cr | ₹562 Cr | ₹478 Cr | ₹385 Cr | ₹311 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,418 Cr | ₹1,385 Cr | ₹1,368 Cr | ₹1,342 Cr | ₹1,111 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹463 Cr | ₹403 Cr | ₹358 Cr | ₹190 Cr | ₹302 Cr |
Non Current Investments | ₹35 Cr | ₹40 Cr | ₹43 Cr | ₹34 Cr | ₹21 Cr |
Long Term Investment | ₹35 Cr | ₹40 Cr | ₹43 Cr | ₹34 Cr | ₹21 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹35 Cr | ₹40 Cr | ₹43 Cr | ₹34 Cr | ₹21 Cr |
Long Term Loans & Advances | ₹37 Cr | ₹53 Cr | ₹57 Cr | ₹94 Cr | ₹43 Cr |
Other Non Current Assets | ₹1.37 Cr | ₹9.87 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr |
Total Non-Current Assets | ₹2,312 Cr | ₹2,207 Cr | ₹2,134 Cr | ₹1,988 Cr | ₹1,730 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr |
Inventories | ₹348 Cr | ₹345 Cr | ₹320 Cr | ₹355 Cr | ₹333 Cr |
Raw Materials | ₹159 Cr | ₹131 Cr | ₹144 Cr | ₹153 Cr | ₹136 Cr |
Work-in Progress | ₹61 Cr | ₹70 Cr | ₹52 Cr | ₹45 Cr | ₹34 Cr |
Finished Goods | ₹49 Cr | ₹82 Cr | ₹65 Cr | ₹75 Cr | ₹89 Cr |
Packing Materials | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr |
Stores  and Spare | ₹52 Cr | ₹40 Cr | ₹37 Cr | ₹53 Cr | ₹38 Cr |
Other Inventory | ₹8.85 Cr | ₹5.18 Cr | ₹5.29 Cr | ₹16 Cr | ₹23 Cr |
Sundry Debtors | ₹441 Cr | ₹392 Cr | ₹324 Cr | ₹386 Cr | ₹234 Cr |
Debtors more than Six months | ₹59 Cr | ₹44 Cr | ₹45 Cr | ₹110 Cr | ₹30 Cr |
Debtors Others | ₹385 Cr | ₹349 Cr | ₹280 Cr | ₹280 Cr | ₹204 Cr |
Cash and Bank | ₹29 Cr | ₹32 Cr | ₹22 Cr | ₹34 Cr | ₹124 Cr |
Cash in hand | ₹0.25 Cr | ₹0.33 Cr | ₹0.30 Cr | ₹0.34 Cr | ₹0.35 Cr |
Balances at Bank | ₹28 Cr | ₹31 Cr | ₹21 Cr | ₹34 Cr | ₹123 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹18 Cr | ₹16 Cr | ₹16 Cr | ₹9.36 Cr | ₹26 Cr |
Interest accrued on Investments | ₹0.25 Cr | ₹0.35 Cr | ₹1.31 Cr | ₹1.58 Cr | ₹1.52 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | ₹0.87 Cr | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹16 Cr | ₹15 Cr | ₹7.84 Cr | ₹6.50 Cr | ₹6.27 Cr |
Other current_assets | ₹1.76 Cr | ₹0.79 Cr | ₹5.51 Cr | ₹1.28 Cr | ₹18 Cr |
Short Term Loans and Advances | ₹151 Cr | ₹91 Cr | ₹88 Cr | ₹102 Cr | ₹146 Cr |
Advances recoverable in cash or in kind | ₹55 Cr | ₹16 Cr | ₹24 Cr | ₹28 Cr | ₹21 Cr |
Advance income tax and TDS | ₹4.73 Cr | ₹4.73 Cr | ₹8.83 Cr | ₹9.04 Cr | ₹8.61 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹91 Cr | ₹71 Cr | ₹55 Cr | ₹65 Cr | ₹117 Cr |
Total Current Assets | ₹986 Cr | ₹876 Cr | ₹770 Cr | ₹887 Cr | ₹862 Cr |
Net Current Assets (Including Current Investments) | ₹311 Cr | ₹183 Cr | ₹-15 Cr | ₹276 Cr | ₹275 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,298 Cr | ₹3,083 Cr | ₹2,904 Cr | ₹2,875 Cr | ₹2,632 Cr |
Contingent Liabilities | ₹76 Cr | ₹100 Cr | ₹186 Cr | ₹104 Cr | ₹48 Cr |
Total Debt | ₹586 Cr | ₹936 Cr | ₹797 Cr | ₹682 Cr | ₹844 Cr |
Book Value | 242.58 | 208.37 | 205.44 | 209.93 | 181.37 |
Adjusted Book Value | 242.58 | 208.37 | 205.44 | 209.93 | 181.37 |
Compare Balance Sheet of peers of SHILPA MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHILPA MEDICARE | ₹7,064.1 Cr | 2.4% | -11.6% | -19.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,140.0 Cr | 2.1% | 2.4% | -11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,290.0 Cr | 0.7% | 8.2% | 8.1% | Stock Analytics | |
CIPLA | ₹132,417.0 Cr | 5.6% | 3.9% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,839.0 Cr | 1.5% | 0.1% | 1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,031.0 Cr | 3.7% | -3% | -6.4% | Stock Analytics |
SHILPA MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHILPA MEDICARE | 2.4% |
-11.6% |
-19.7% |
SENSEX | 2.5% |
2% |
3.1% |
You may also like the below Video Courses